Listed

Nephros Inc: Form 10-Q for the period ended Sep 30, 2014

Filed with the SEC on Nov 13, 2014 and accepted by EDGAR at Nov 13, 2014, 16:30 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-07-01 to 2014-09-30$491.0kus-gaap:SalesRevenueNet
Revenue9 months2014-01-01 to 2014-09-30$1.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2014-07-01 to 2014-09-30$175.0kus-gaap:CostOfGoodsSold
Cost of revenue9 months2014-01-01 to 2014-09-30$423.0kus-gaap:CostOfGoodsSold
Gross profit3 months2014-07-01 to 2014-09-30$316.0kus-gaap:GrossProfit
Gross profit9 months2014-01-01 to 2014-09-30$983.0kus-gaap:GrossProfit
Selling, general and administrative3 months2014-07-01 to 2014-09-30$765.0kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2014-01-01 to 2014-09-30$2.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-07-01 to 2014-09-30−$681.0kus-gaap:OperatingIncomeLoss
Operating income9 months2014-01-01 to 2014-09-30−$1.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-07-01 to 2014-09-30$65.0kus-gaap:InterestExpense
Interest expense9 months2014-01-01 to 2014-09-30$277.0kus-gaap:InterestExpense
Net income3 months2014-07-01 to 2014-09-30−$706.0kus-gaap:NetIncomeLoss
Net income9 months2014-01-01 to 2014-09-30−$2.1mus-gaap:NetIncomeLoss
Operating cash flow9 months2014-01-01 to 2014-09-30−$1.7mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2014-09-30$1.0mus-gaap:Cash
Current assetsAt period end2014-09-30$1.4mus-gaap:AssetsCurrent
Total assetsAt period end2014-09-30$3.1mus-gaap:Assets
Current liabilitiesAt period end2014-09-30$3.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-09-30$3.5mus-gaap:Liabilities
Shareholders' equityAt period end2014-09-30−$386.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-067766. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.